Capex (fluocinolone acetonide) / Galderma - LARVOL DELTA

Ethinylestradiol removal of membrane bioreactor effluent by reverse osmosis and UV/HO: A technical and economic assessment. (PubMed, J Environ Manage) - "In turn, route MBR-RO increased the total process cost by US$ 0.86/m, showing that reduction of volume to be treated by UV/HO in this route did not offset the cost associated with the acquisition and operation of RO. The total cost was estimated at US$ 2.47/m for MBR-AOP and US$ 2.94/m for MBR-RO for a design flow of 10 m³/h."

Journal

Low-pressure membrane technology for potable water filtration: true costs. (PubMed, Water Res) - "Outcomes indicate labour costs associated with process upsets to contribute significantly to the overall cost of the installation over its life cycle, particularly at flows below ~30,000 m/d. A clear trade-off exists between supplementary capital investment to allay process upsets and the operational costs associated with such events."

Journal